Role(s) in Healthcare Innovation:
PhysicianMy Communities
NOLA Health Innovators Global Healthcare InnovationEnrique Gutierrez, MD
About Me
Physician practicing in Kissimmee for over 20 years. Specialize in treating patients with HIV. Completed a specialty fellowship in Allergy and Immunology and Endocrinology at the prestigious Tulane University. Tulane University is one of the top endocrinology programs in the nation attending Tulane gave him the opportunity to train under Nobel Prize winning academicians.Also trained under the founder of the American Academy of Allergy and Clinical Immunology. During his time there he conducted and published ground breaking research in the area of neuro endocrinology and neuro immunology. He has led many pharmaceutical clinical trials and collaborated in developing new drugs with different pharmaceutical companies . His present research is primarily focused on vanadium compound and micronized glyburide for the treatment of HIV and other viral diseases.
Interested in solutions for:
I am working on a great new idea for healthcareI am looking for healthcare innovations:
Biotech Drug Development Infectious Disease
You have not backed any projects.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No project reviewed yet.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.